GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus. - Wikidata - awgldk - TriplyDB

GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.

GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.

http://www.wikidata.org/entity/Q34013791

about

Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer Myosins as fundamental components during tumorigenesis: diverse and indispensable Novel RNA markers in prostate cancer: functional considerations and clinical translation Disease Biomarker Query from RNA-Seq Data.TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling.Xenopus as a model system for the study of GOLPH2/GP73 function: Xenopus GOLPH2 is required for pronephros development.GOLPH2 expression may serve as diagnostic marker in seminomas.Evaluation of ERG responsive proteome in prostate cancer Contribution of the myosin VI tail domain to processive stepping and intramolecular tension sensing.Myosin VI is differentially regulated by DNA damage in p53- and cell type-dependent manners Novel diagnostic biomarkers for prostate cancer.GOLPH2 expression in renal cell cancer A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73.Golgi phosphoprotein 2 (GOLPH2) is a novel bile acid-responsive modulator of oesophageal cell migration and invasion.Downregulation of myosin VI reduced cell growth and increased apoptosis in human colorectal cancer.Distinct genomic aberrations associated with ERG rearranged prostate cancer Diagnostic and prognostic molecular biomarkers for prostate cancer.Golgi phosphoprotein 2 in physiology and in diseases.Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer.Myosin VI contributes to malignant proliferation of human glioma cells.Knockdown of Myosin 6 inhibits proliferation of oral squamous cell carcinoma cells.Knockdown of Myosin VI Inhibits Proliferation of Hepatocellular Carcinoma Cells In Vitro.Lentivirus-Mediated Silencing of Myosin VI Inhibits Proliferation and Cell Cycle Progression in Human Lung Cancer Cells.Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer.Overexpression of myosin VI in prostate cancer cells enhances PSA and VEGF secretion, but has no effect on endocytosis.Golgi-Related Proteins GOLPH2 (GP73/GOLM1) and GOLPH3 (GOPP1/MIDAS) in Cutaneous Melanoma: Patterns of Expression and Prognostic Significance.Generation and characterization of an anti-GP73 monoclonal antibody for immunoblotting and sandwich ELISA.GP73 is a potential marker for evaluating AIDS progression and antiretroviral therapy efficacy.GP73 regulates Hepatic Steatosis by enhancing SCAP-SREBPs interaction.Markers of clinical utility in the differential diagnosis and prognosis of prostate cancer.Lidocaine inhibits the proliferation of lung cancer by regulating the expression of GOLT1A.GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.GOLPH2, a gene downstream of ras signaling, promotes the progression of pancreatic ductal adenocarcinoma.Golgi protein 73 as a biomarker of hepatocellular cancer: development of a quantitative serum assay and expression studies in hepatic and extrahepatic malignancies.

P2860

Q24649955-9A93BFA4-2FEC-47A2-A51F-029F0861F58D Q26749344-B2C57DAA-9125-4A23-B584-3F13F1B90E1F Q27021174-FA6DBDA2-817A-40B6-BCDF-F59DB6BC277D Q30869256-622444F9-205D-496B-BF2B-42B4D71C5B4C Q31042968-A0082315-EF8B-4CF8-AF40-A6AF71435F5A Q31068632-FE2BF967-0749-4698-920A-EA9D623F1DDF Q33534479-05DA2714-CA01-4254-BF00-042E8FD449E6 Q33822319-65FA4097-2E2D-439D-A5C9-BC80FBB26E2A Q33842753-3823A2AC-12EA-4E43-A204-557A37971FCB Q34094507-EED7A1D6-1A4C-49F0-9040-3C30F6D873CA Q34231678-1FC65705-B366-49C3-BAE5-E24A9F27B99C Q34600429-75448246-3E65-490A-BFB9-39EBB3D04A70 Q35248192-F0542BFE-52A5-4220-B7E6-B3F4BF34E429 Q36393694-B8075A97-60CB-4042-8646-53BABB81ADAE Q36750617-7822765A-0368-4A02-B976-5EF0DE46CACE Q36954842-A9C4C654-58F9-41FE-A822-ED6FCD80FB14 Q37173727-BAB4ABAF-501D-4E18-A755-A0D01194024F Q37972703-98933888-E248-48B2-8217-C4DC16E64304 Q38041690-B54E38E1-3808-4E56-B0E0-37D205D5A606 Q38350670-1E0EE76B-0CBC-493D-A10A-D454EF64A703 Q38666218-5222B3BD-DBBE-4D1E-9623-1EFFC804F7A1 Q38736867-944DD109-3E54-41B9-86DC-C2CF3FB39277 Q38907172-83193EB4-6901-42EB-B36C-55441D7FCABA Q38913936-A5F1DEBA-EADB-4835-BA23-40F4E30304E2 Q39329100-880CC009-0674-4895-A4BD-C9D98113EC25 Q39783600-A4724EB5-1590-485D-8918-7BB457D3E16F Q40553485-7261A54D-30AD-414C-B4A9-997DC73FBC63 Q41147066-67E94C33-3640-4454-9C12-8E18736900D3 Q42266868-B297DE71-A08E-4379-B5C4-8C9C1CFDB83F Q47129296-91623AE2-7DA1-4EE4-BAD1-E560350D5BB8 Q47215343-31FA75F5-E392-4CE4-B440-591F6D2C54B2 Q47271028-4537A0F9-5AF0-4D25-B376-BE4491818692 Q47357247-4E57E410-0260-4F97-84D7-7793FF9A8662 Q47726218-90E7A027-CC46-4175-A06D-0F0838265651 Q47919341-6BDC837A-93B7-4565-8FDC-5FAE62FAC5CA

P2860

GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.

http://www.wikidata.org/entity/Q34013791

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.

@ast

GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.

@en

GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.

@nl

type

label

GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.

@ast

GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.

@en

GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.

@nl

prefLabel

GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.

@ast

GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.

@en

GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.

@nl

P1433

Q34013791-38C6F026-4CE0-4427-B05E-4E3BAD5570F3

P1476

Q34013791-3B366C28-6593-4E1E-B203-E4CFA0A0CBF5

P2093

Q34013791-6A591F60-B537-41EB-A09D-931F8B900C56

Q34013791-7E9FBE73-7F24-4934-86CE-3926796BFA02

Q34013791-AEF6B63F-BAF3-494E-A6EC-830EA1B405E1

Q34013791-EDB15C64-60AD-4CD6-808A-371F6619A350

P2860

Q34013791-07B23233-C30D-44F6-AFE1-A80EADE48D0F

Q34013791-2365D17B-0318-4679-B868-D3B6C404660D

Q34013791-2B4973FD-9D45-4EC9-A961-BD6DD9911F8C

Q34013791-33284551-D33E-4DE9-8A4F-9328542CA512

Q34013791-46A15903-FA61-4BC5-B683-192774B7335D

Q34013791-4DE8483D-0919-42BA-927F-10000492CC09

Q34013791-57284A1A-00F9-46FA-AD21-7349BAA76C8D

Q34013791-5CADFF65-90D9-4140-AF17-967AD002892E

Q34013791-66DBC9D3-A410-4AEB-93B2-C054BF85E5CB

Q34013791-7F830611-28C6-4D4C-A5C5-F702234D4976

P304

Q34013791-5FAF6CAE-57A9-4A6F-BDF5-78DC5BDA86A7

P31

Q34013791-0B5C3905-8294-42B5-A98E-F31BC978FA92

P356

Q34013791-0708557A-4CF0-4862-AB02-5CB89AA9AEB8

P433

Q34013791-66BED2C0-99FC-4107-B39E-6F9BBCE42774

P478

Q34013791-A555AA1F-93D1-43C7-AAEF-9C23B4E524EB

P50

Q34013791-AB3DE174-4F67-4CB5-A6D2-0B0ABA818709

P577

Q34013791-50A5395F-CA76-4968-A77E-0BCC90F718A2

P698

Q34013791-F55864D0-FFF6-43BC-88A5-D395B2FF7467

P921

Q34013791-270A6474-32C8-41D6-ACF9-272E0154F33E

P932

Q34013791-6E8202A5-75F2-4711-8134-3F8E7FD457C4

P356

P1433

P1476

GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus

@en

P2093

Angelo M De Marzo

http://www.w3.org/2001/XMLSchema#string

Jun Luo

http://www.w3.org/2001/XMLSchema#string

Thomas A Dunn

http://www.w3.org/2001/XMLSchema#string

William B Isaacs

http://www.w3.org/2001/XMLSchema#string

P2860

GP73, a novel Golgi-localized protein upregulated by viral infection

Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis

Asymmetric CLASP-dependent nucleation of noncentrosomal microtubules at the trans-Golgi network

A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer

How are the cellular functions of myosin VI regulated within the cell?

Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.

Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.

Cycling of early Golgi proteins via the cell surface and endosomes upon lumenal pH disruption.

Lessons from border cell migration in the Drosophila ovary: A role for myosin VI in dissemination of human ovarian cancer.

Primate homologues of rat TGN38: primary structure, expression and functional implications.

P304

1387-1395

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.20806

http://www.w3.org/2001/XMLSchema#string

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18543251

http://www.w3.org/2001/XMLSchema#string

P921

Golgi apparatus

P932

4124602

http://www.w3.org/2001/XMLSchema#string